Skip to main content

Press releases 2013

2013-12-20
On December 6, 2013, Moberg Pharma announced the acquisition of three Over-The-Counter brands in the U.S. from Bayer HealthCare, LLC. The acquisition has now been completed. The purchase price amounted to 4.8 MUSD.
2013-12-13
Moberg Pharma AB (OMX: MOB) today announced positive interim results from its ongoing phase ll study of MOB-015. After six months of treatment with MOB-015, 40 per cent of the patients were mycologically cured and no safety concerns were identified. MOB-015 is a novel topical formulation of terbinafine for the treatment of nail fungus (onychomycosis).
2013-12-06
Moberg Pharma AB (OMX: MOB) has signed a deal to acquire three well established Over-The-Counter brands in the U.S. from Bayer HealthCare, LLC. Total annual sales for the brands are approximately 20 MSEK (ca 3 m$). The purchase price is 32 MSEK (4.8 m$) and is financed by available cash resources.
2013-11-25
Walgreens has decided to increase the number of stores selling Kerasal Neurocream™ in U.S. from approximately 1 000 to 7 000 stores. Walgreens is the leading drugstore chain in the U.S. and the increased distribution is an important step towards establishing this innovative product in the marketplace.
2013-11-08
In accordance with the resolution of the Annual General Meeting on April 23, 2013, the Chairman of the Board has contacted the company’s three largest shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee.
2013-11-05
KERASAL NAIL IS MARKET LEADER IN U.S.
2013-10-25
Moberg Pharma AB (OMX: MOB) today signed an exclusive agreement with Leosons International to distribute Moberg’s Kerasal Nail™ in MENA (Middle East and North Africa). Leosons has been successfully distributing Moberg’s JointFlex® brand in the Middle East for almost 10 years.  Leosons intends to launch Kerasal Nail™ in 2014.
2013-10-14
Moberg Pharma North America continues to expand distribution of Kerasal Nail outside of the drug class of trade with the addition of Kmart mass retail stores.
2013-09-11
The largest drugstore chain in Canada has made their first orders
2013-08-12
Moberg Pharma AB (OMX: MOB) today announced its U.S. launch of Kerasal® NeuroCream, an over the counter pain relieving foot cream. This new product will be sold in over 3,800 Walmart stores and in CVS, Walgreens, and Rite Aid drug stores starting late August.
2013-08-06
CONTINUED GROWTH AND INCREASED FINANCIAL STRENGTH PREPARING FOR PORTFOLIO EXPANSION
2013-07-31
The number of shares and votes in Moberg Pharma AB (publ) has increased by 1,081,000 to 11,893,572 during July 2013. Therefore, there are in total 11,893,572 shares and votes in the company as of July 31st, 2013.
2013-07-22
Moberg Pharma AB (OMX: MOB) today announced that Menarini Asia-Pacific, a member of the Menarini Group – a top 40 global pharmaceutical company – has been granted the exclusive rights to market and sell Kerasal Nail™ in China. The companies now intend to seek marketing authorization for the product in the Chinese market.
2013-07-16
Opening orders received from 200 Meijer Hypermarket stores and 170 Hannaford Supermarkets
2013-07-12
Moberg Pharma today launched a new website with expanded information for investors - including detailed financial statistics - as well as in-depth information about Moberg Pharma's products and partners.
2013-07-02
Stockholm, July 2, 2013. Based on the authorization from the 2013 Annual General Meeting, the Board of Moberg Pharma AB (OMX: MOB)(“Moberg Pharma”, the “Company” or the “Group”) has resolved to issue new shares with deviation from the shareholders’ preferential rights to Bure Equity AB (publ) (“Bure”). The purpose of the financing is to facilitate forthcoming additions to the Company´s product portfolio.
2013-05-27
Moberg Pharma AB (OMX: MOB) today announced the completion of patient enrollment in the ongoing Phase II clinical trial of MOB-015. MOB-015 is a topical formulation of terbinafine for the treatment of nail fungus (onychomycosis).
2013-05-21
CONTINUED STRONG GROWTH - MOBERG DERMA BECOMES MOBERG PHARMA
2013-05-20
Moberg shipped its first orders to HEB supermarket stores in Texas.
2013-05-13
Moberg Pharma AB (OMX: MOB) today announced that Paladin has been granted the exclusive rights to market and sell Kerasal Nail™ in Mexico. Kerasal Nail™ is an over-the-counter (OTC), topical product with a unique mechanism of action that generates visible improvements within 2-4 weeks of treatment. Further details or financial terms of the transaction were not disclosed.
2013-05-02
Moberg Derma AB (OMX: MOB) announced today that the Swedish Companies Registration Office has granted the company's application for a name change to Moberg Pharma AB (publ), in accordance with the decision of the AGM on 23 April 2013.
2013-04-30
Kerasal Nail is the fastest growing product in the fungal nail category in in pharmacies and Walmart stores in the United States.
2013-04-23
Moberg Derma AB’s Annual General Meeting took place on Monday, April 23, 2013 in the company´s premises in Bromma.
2013-03-26
After implementation of new marketing programs, retail sales of Kerasal Exfoliating Foot Ointment grew at over 14% last 3 months compared to the same period last year.
2013-03-25
Shareholders in Moberg Derma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Tuesday, April 23, 2013 at 4:00 p.m. in the Company´s premises in Bromma, address Gustavslundsvägen 42, 5 tr, 167 51 Bromma (Alviks torg), Sweden.
2013-03-11
Moberg Derma AB (OMX: MOB) has decided to discontinue the development of Limtop - a drug candidate for the treatment of actinic keratosis. The decision is based on data from a completed phase II clinical trial, where the efficacy of Limtop did not reach the predefined target.
2013-02-05
DOUBLED REVENUE, PROFITABLE AND ESTABLISHMENT IN THE U.S.
2013-01-12
Moberg Pharma North America has begun shipping Kerasal Nail to 250 Duane Reade pharmacy and convenience stores in New York City.